Literature DB >> 10843535

HIV-1 transmission in injection paraphernalia: heating drug solutions may inactivate HIV-1.

M C Clatts1, R Heimer, N Abdala, L A Goldsamt, J L Sotheran, K T Anderson, T M Gallo, L D Hoffer, P A Luciano, T Kyriakides.   

Abstract

In response to recent concerns about risk of HIV-1 transmission from drug injection paraphernalia such as cookers, ethnographic methods were used to develop a descriptive typology of the paraphernalia and practices used to prepare and inject illegal drugs. Observational data were then applied in laboratory studies in which a quantitative HIV-1 microculture assay was used to measure the recovery of infectious HIV-1 in cookers. HIV-1 survival inside cookers was a function of the temperature achieved during preparation of drug solutions; HIV-1 was inactivated once temperature exceeded, on average, 65 degrees C. Although different types of cookers, volumes, and heat sources affected survival times, heating cookers 15 seconds or longer reduced viable HIV-1 below detectable levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10843535     DOI: 10.1097/00126334-199910010-00013

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  28 in total

1.  Explaining the geographical variation of HIV among injection drug users in the United States.

Authors:  D Ciccarone; P Bourgois
Journal:  Subst Use Misuse       Date:  2003-12       Impact factor: 2.164

2.  First injection of ketamine among young injection drug users (IDUs) in three U.S. cities.

Authors:  Stephen E Lankenau; Bill Sanders; Jennifer Jackson Bloom; Dodi Hathazi; Erica Alarcon; Stephanie Tortu; Michael C Clatts
Journal:  Drug Alcohol Depend       Date:  2006-09-18       Impact factor: 4.492

Review 3.  Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections.

Authors:  Jesus Bucardo; Kimberly C Brouwer; Carlos Magis-Rodríguez; Rebeca Ramos; Miguel Fraga; Saida G Perez; Thomas L Patterson; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2005-04-01       Impact factor: 4.492

4.  Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.

Authors:  Luis de la Fuente; María José Bravo; Carlos Toro; M Teresa Brugal; Gregorio Barrio; Vicente Soriano; Fernando Vallejo; Rosario Ballesta
Journal:  J Epidemiol Community Health       Date:  2006-06       Impact factor: 3.710

5.  Novel heroin injection practices: implications for transmission of HIV and other bloodborne pathogens.

Authors:  Michael C Clatts; Le M Giang; Lloyd A Goldsamt; Huso Yi
Journal:  Am J Prev Med       Date:  2007-06       Impact factor: 5.043

6.  Crack Cocaine Injection Practices and HIV Risk: Findings From New York and Bridgeport.

Authors:  Stephen E Lankenau; Michael C Clatts; Lloyd A Goldsamt; Dorinda L Welle
Journal:  J Drug Issues       Date:  2004

7.  Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.

Authors:  Michael C Clatts; Vivian Colón-López; Le M Giang; Lloyd A Goldsamt
Journal:  J Urban Health       Date:  2010-03       Impact factor: 3.671

8.  Injection and sexual risk practices among young heroin users in Hanoi, Vietnam.

Authors:  Lloyd A Goldsamt; Michael C Clatts; Giang Le; Gary Yu
Journal:  Drugs (Abingdon Engl)       Date:  2015-04

9.  The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus; Mary M Mitchell; Eszter Ujhelyi
Journal:  Drug Alcohol Depend       Date:  2008-12-05       Impact factor: 4.492

10.  Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.

Authors:  Saira S Siddiqui; Richard F Armenta; Jennifer L Evans; Michelle Yu; Jazmine Cuevas-Mota; Kimberly Page; Peter Davidson; Richard S Garfein
Journal:  Int J Drug Policy       Date:  2015-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.